Today: 24 December 2025
Subscribe
Browse Tag

SEC approval

CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025Company: CME Group Inc. (NASDAQ: CME) CME Group stock ended the week on a steadier footing after a midweek dip, closing at $273.55 on Friday, Dec. 12 (up 0.42% on the day). Finviz That finish capped
13 December 2025
 ·  ·  ·  ·  · 
CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group Inc. (NASDAQ: CME), the world’s largest derivatives exchange operator, has packed a lot of news into the turn of the month. On December 2, 2025, the company reported near-record trading volumes, secured U.S. regulatory approval for a new
3 December 2025
 ·  ·  ·  ·  · 
Go toTop